Stride (LRN) analyst forecast and price target
Analyst forecast
Consensus of 6 analyst ratings
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BMO Capital | Maintained | Market Perform | $90.00 from $93.00 | Oct 5, 2026 |
| Barrington Research | Maintained | Outperform | $125.00 | Apr 16, 2026 |
| Barrington Research | Maintained | Outperform | $125.00 | Jan 28, 2026 |
| Canaccord Genuity | Maintained | Buy | $125.00 | Jan 28, 2026 |
| Barrington Research | Maintained | Outperform | $125.00 | Jan 21, 2026 |
| Morgan Stanley | Maintained | Equal-Weight | $95.00 from $130.00 | Dec 17, 2025 |
| BMO Capital | Downgraded | Outperform → Market Perform | $108.00 from $164.00 | Oct 29, 2025 |
| Barrington Research | Maintained | Outperform | $125.00 from $185.00 | Oct 29, 2025 |
| Canaccord Genuity | Maintained | Buy | $125.00 from $175.00 | Oct 29, 2025 |
| Canaccord Genuity | Maintained | Buy | $175.00 from $165.00 | Oct 24, 2025 |
| Barrington Research | Maintained | Outperform | $185.00 | Sep 23, 2025 |
| Barrington Research | Maintained | Outperform | $185.00 from $170.00 | Aug 29, 2025 |
| Morgan Stanley | Maintained | Equal-Weight | $159.00 from $148.00 | Aug 6, 2025 |
| Barrington Research | Maintained | Outperform | $170.00 | Jul 24, 2025 |
| Barrington Research | Maintained | Outperform | $170.00 from $150.00 | Apr 30, 2025 |
| Canaccord Genuity | Maintained | Buy | $155.00 from $145.00 | Apr 28, 2025 |
| Barrington Research | Maintained | Outperform | $150.00 from $140.00 | Apr 17, 2025 |
| BMO Capital | Maintained | Outperform | $139.00 from $134.00 | Apr 1, 2025 |
| Barrington Research | Maintained | Outperform | $140.00 | Mar 14, 2025 |
| Canaccord Genuity | Maintained | Buy | $145.00 from $135.00 | Mar 11, 2025 |
Frequently asked questions
Is LRN a buy, sell, or hold?
Analysts covering Stride currently average a Buy rating: 4 buy, 2 hold and 0 sell, from 6 analysts. Ratings reflect analyst opinion, not investment advice.
What is the latest analyst rating on LRN?
On Oct 5, 2026, BMO Capital maintained Stride at Market Perform with a price target of $90.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.